Northern Ireland Blood Transfusion Service

What Northern Ireland Blood Transfusion Service does

The Northern Ireland Blood Transfusion Service (NIBTS) is the statutory, sole regional provider of blood and blood components for Northern Ireland, operating as an independent Special Agency of the Department of Health (Northern Ireland). Established in 1946 and headquartered in a purpose-built facility on the Belfast City Hospital campus since 1995, NIBTS collects, tests, processes, and distributes over 55,000 blood donations annually, conducting around 800 donation sessions per year across three mobile Bloodmobiles and the headquarters suite. It supplies all hospitals and clinical units in Northern Ireland with red cells, platelets, plasma, cryoprecipitate, and plasma derivatives, with components produced locally and plasma fractions sourced from licensed fractionators.

NIBTS's operational infrastructure is built around the PULSE computer system, which provides end-to-end chain-of-custody tracking from donor registration through hospital distribution, assigning unique donation identifiers to every pack, sample, and document. The on-site Blood Safety laboratory conducts comprehensive serological and nucleic acid testing (NAT) for Hepatitis B, C, A, and E, HIV, Syphilis, HTLV, and targeted pathogens including malaria, T. cruzi, and CMV. The service operates under the UK Blood Safety and Quality Regulations (2005), JPAC guidelines, and SaBTO 2020 consent recommendations.

NIBTS is a government-funded public health service with no commercial revenue model: blood and blood products are supplied to hospitals free of charge, donations are voluntary and unpaid, and funding flows through Department of Health appropriations under a Partnership Agreement. The customer base is effectively the Northern Ireland Health and Social Care system (all hospitals and clinical units), making NIBTS a single-buyer, single-seller arrangement within the public sector. The organisation is also engaged in the regional Pathology Blueprint Programme, which proposes consolidating NIBTS with NI Pathology Network and Trust laboratory services into a single regional Pathology Special Agency.

Name

Northern Ireland Blood Transfusion Service

Legal name

Northern Ireland Blood Transfusion Service

Website

https://nibts.hscni.net

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

11–50 employees

Short description

Northern Ireland Blood Transfusion Service (NIBTS) is the statutory sole provider of blood and blood components to all hospitals and clinical units in Northern Ireland, collecting over 55,000 donations annually via headquarters and three mobile Bloodmobiles under Department of Health funding.

Ownership category

akta.pro rank

Product category

Blood Transfusion Services

NAICS

Blood and Organ Banks (621991)

SIC

Services-Medical Laboratories (8071), Services-Health Services (8000)

akta.pro primary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

akta.pro secondary industries

Blood, Organ & Tissue Donation Organizations (BPAGACAJ), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

Keywords

• Blood transfusion services
• Blood component processing
• Donor management
• Blood safety testing
• Platelet donation

Headquarters

HQ city

Belfast

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Government-Funded Public Health Service: NIBTS operates as an independent, Special Agency of the Department of Health (DHSSPS). As a public health service, it is funded through government appropriations to fully supply the blood transfusion needs of all hospitals and clinical units in Northern Ireland. Blood and blood products are provided to hospitals; there is no commercial transaction with patients.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

The Northern Ireland Blood Transfusion Service collects, tests, and distributes over 55,000 blood donations each year to all hospitals and clinical units in Northern Ireland. It operates three mobile units at nearly 180 locations and runs almost 800 donation sessions annually, providing whole blood, platelets, and processed components (red cells, plasma, cryoprecipitate) supported by comprehensive safety testing including nucleic acid testing (NAT).

Product overview

NIBTS operates as a unified blood transfusion service providing collection, testing, and distribution of blood and blood products. The core offerings include Whole Blood Donation through mobile units at nearly 180 locations, Platelet Donation via appointment at headquarters using plateletpheresis, and Blood Components (Plasma, Red Cells, Cryoprecipitate, Platelets). The PULSE internal system manages donor records and tracking. All donations undergo mandatory safety testing for infections including Hepatitis B/C/E, HIV, Syphilis, and HTLV. Over 55,000 blood donations are collected annually through approximately 800 donation sessions.

Differentiator

Problem solved

Functional benefit

Products and services

• Whole Blood Donation
• Platelet Donation

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators6 records

Recent moves8 records

Expansion highlights10 records

Direct peers

• NHS Blood and Transplant: The UK-wide NHS body responsible for blood and organ donation, collection, testing and transplantation. Directly comparable as the analogous public-sector blood service operating across England and Wales with a similar statutory mandate and end-to-end blood supply chain.
• Scottish National Blood Transfusion Service: The devolved Scottish public-sector blood service within NHS Scotland, performing whole blood and platelet collection, processing, testing and hospital distribution. Closely comparable in mandate, scale of national territory served, and mobile-donor-clinic operating model.
• Welsh Blood Service: The Wales-based division of the Welsh Government's Velindre University NHS Trust that collects, tests and distributes blood products. Directly comparable in delivering regional transfusion services under public-sector governance with a similar donor-recruitment model.
• Irish Blood Transfusion Service: The Republic of Ireland's national blood service responsible for collection, processing, testing and distribution. Comparable as a neighboring national blood service operating under similar EU/UK regulatory frameworks with mobile and fixed-site donation models.

Broad incumbents

• Vitalant: One of the largest nonprofit blood collectors in the United States, supplying hospitals across many states. Comparable in end-to-end blood collection, testing and distribution, though operating in a fragmented, multi-competitor US market rather than a sole-provider regional model.
• Australian Red Cross Lifeblood: Australia's national blood authority collecting and distributing blood and plasma products across a much larger geography. Comparable in operating a publicly accountable, end-to-end blood supply chain, though at significantly greater scale and with broader plasma fractionation activities.
• American Red Cross Blood Services: The largest single supplier of blood products in the United States, collecting and distributing across the majority of US states. Comparable as a national-scale, mission-driven blood collection and distribution organization, though operating within a competitive market.
• Canadian Blood Services: Canada's national, not-for-profit charitable blood operator managing collection, testing and hospital distribution across provinces and territories. Comparable as a public-mandate blood service, though operating across a much larger and more complex multi-jurisdictional footprint.
• New York Blood Center: A large nonprofit community blood center serving a major US metropolitan and regional network. Comparable as a full-service blood collector and distributor operating mobile donor programs with an established regional hospital footprint.

Emerging players

• CSL Plasma: A major commercial plasma collection network sourcing plasma for fractionation into therapies. Comparable in operating a large-scale donor center network for biological products, but with a commercial, paid-donor model focused on plasma rather than whole blood for transfusion.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/givebloodni
• LinkedInlinkedin.com/company/northernirelandbloodtransfusionservice

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Northern Ireland Blood Transfusion Service